The complex regulation of Rab1 GTPases and their impact on Golgi dynamics, tau secretion in Alzheimer’s disease, and motor function in Parkinson’s disease underscore the therapeutic promise of targeting Rab1A in neurodegenerative processes. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.